Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.

[1]  I. Elgendy,et al.  FFR- Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease: A Network Meta-Analysis. , 2022, JACC. Cardiovascular interventions.

[2]  Theresa M. Beckie,et al.  2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Circulation.

[3]  Weichao Huang,et al.  Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.

[4]  G. Chatellier,et al.  Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. , 2021, The New England journal of medicine.

[5]  Ulf J Jensen,et al.  Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. , 2020, Journal of the American College of Cardiology.

[6]  D. Wood,et al.  Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction , 2020, Circulation. Cardiovascular interventions.

[7]  M. Jeong,et al.  Coronary Circulatory Indexes in Non-Infarct-Related Vascular Territories in a Porcine Acute Myocardial Infarction Model. , 2020, JACC. Cardiovascular interventions.

[8]  T. Thim,et al.  Evaluation and Management of Nonculprit Lesions in STEMI. , 2020, JACC. Cardiovascular interventions.

[9]  D. Wood,et al.  Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. , 2020, JAMA cardiology.

[10]  A. Colombo,et al.  Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? , 2020, European heart journal. Quality of care & clinical outcomes.

[11]  A. M. Leone,et al.  Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis: A Single-Center Trial. , 2020, JACC. Cardiovascular interventions.

[12]  David L. Brown,et al.  The fallacies of fractional flow reserve. , 2019, International journal of cardiology.

[13]  Á. Avezum,et al.  Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.

[14]  S. Girotra,et al.  Network Meta-analysis of percutaneous intervention-based revascularization strategies for ST-elevation myocardial infarction and concomitant multi-vessel disease. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[15]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  G. Dangas,et al.  Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials. , 2018, JACC. Cardiovascular interventions.

[17]  F. Neumann,et al.  Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.

[18]  I. Elgendy,et al.  A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease. , 2016, Journal of interventional cardiology.

[19]  G. Casella,et al.  Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease , 2016, Internal and Emergency Medicine.

[20]  L. Køber,et al.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[21]  H. Swanton,et al.  Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.

[22]  Manesh R. Patel,et al.  Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. , 2014, JAMA.

[23]  R. de Caterina,et al.  The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. , 2013, International journal of cardiology.

[24]  C. Berry,et al.  Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.

[25]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[26]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[27]  J. Ottervanger,et al.  Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial , 2012, Netherlands Heart Journal.

[28]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[29]  G. Sangiorgi,et al.  A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.

[30]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[31]  B. Gersh,et al.  Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2007, European heart journal.

[32]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[33]  M. Bonardi,et al.  Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study , 2004, International journal of cardiovascular interventions.

[34]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[35]  Douglas Weaver,et al.  Third universal definition of myocardial infarction. , 2012, Circulation.